Has Sandra Hollander received payments from drug or device companies?

Yes. Drug and device makers reported $5,757 in general payments to Sandra Hollander across 337 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandra Hollander did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandra Hollander come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandra Hollander

Hematology & Oncology · Dublin, GANPI 1225168248

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 337 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,812 and has fallen 74.9% since, to $456 in 2023.

$5,757in general payments, 2019–2025

Across 337 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Seagen Inc.$734
Novartis$616
Amgen$516
Coherus Oncology, Inc.$448
AstraZeneca$429
Daiichi Sankyo Inc.$380
plus $3K from 43 others

What the payments were for

Food & beverage$5,51996%
Education$2374%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Seagen Inc.	34	$734
Novartis	35	$616
Amgen	34	$516
Coherus Oncology, Inc.	24	$448
AstraZeneca(2 entities)	28	$429
Daiichi Sankyo Inc.	27	$380
Merck	24	$313
Incyte Corporation	15	$260
GSK	10	$218
Sanofi	8	$155
Johnson & Johnson	7	$149
Takeda Pharmaceuticals U.S.A., Inc.	6	$108
Regeneron Healthcare Solutions, Inc.	5	$96
Bristol Myers Squibb	6	$96
Karyopharm Therapeutics Inc.	3	$82
AMAG Pharmaceuticals, Inc.	6	$78
Pfizer	4	$67
Helsinn Therapeutics (U.S.), Inc.	4	$60
G1 Therapeutics, Inc.	4	$59
Servier Pharmaceuticals LLC	4	$56
Bayer	3	$56
Array Biopharma Inc	3	$53
Pharmacyclics LLC, An Abbvie Company	3	$50
Teva Pharmaceuticals USA, Inc.	4	$49
Puma Biotechnology, Inc.	3	$49
Pharmacosmos Therapeutics Inc.	3	$48
Genentech USA, Inc.	3	$48
Exelixis Inc.	3	$45
Deciphera Pharmaceuticals Inc.	2	$33
E.r. Squibb & Sons, L.L.C.	2	$33
Beigene USA, Inc.	2	$33
Boehringer Ingelheim	1	$31
Stemline Therapeutics Inc.	1	$28
Bio Products Laboratory USA, Inc.	1	$25
Amneal Pharmaceuticals LLC	1	$24
Ipsen Biopharmaceuticals, Inc	1	$23
ADMA Biomanufacturing LLC	1	$21
Sanofi-aventis U.S. LLC	1	$21
Morphosys, US Inc.	1	$19
CTI Biopharma Corp.	1	$18
Global Blood Therapeutics, Inc.	1	$18
AbbVie	1	$18
Rigel Pharmaceuticals, Inc.	1	$16
Tesaro, Inc.	1	$16
EMD Serono, Inc.	1	$15
Lilly USA, LLC	1	$15
Jazz Pharmaceuticals Inc.	1	$14
Blueprint Medicines Corporation	1	$12
Clovis Oncology, Inc.	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Udenyca$121

How this compares

$5,757 in reported general payments places this provider in the 55th percentile of 370 hematology & oncology providers in Georgia.

See all hematology & oncology providers in Georgia →

Other hematology & oncology in Dublin

Priya RudolphAthens$745K
Aron KefelaHiram$591K
Chandar BhimaniConyers$483K
Ticiana LealAtlanta$450K
Steven McCuneMarietta$450K
Jorge LeguizamoLawrenceville$409K
Trevor FeinsteinFayetteville$341K
Jigarkumar ParikhAugusta$267K
Ajay NookaAtlanta$222K
Abdullah KutlarAugusta$196K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →